Drugs / 683699
last change Jul 2006 re-read 3 minutes ago

683699

Developed for
Crohn disease
Investigated by
GlaxoSmithKline

Trials 1

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00101946 Oct 2004 → Jul 2006 Crohn disease GlaxoSmithKline Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 683699 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00101946 ↗